Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

Share Price Information for Brand Architek. (BAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 26.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 3.00 (11.538%)
Open: 27.50
High: 27.50
Low: 27.50
Prev. Close: 27.50
BAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Resolution of Legal Claim

20 Jul 2023 07:00

RNS Number : 5836G
Brand Architekts Group PLC
20 July 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (THE "EUWA")) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

Brand Architekts Group PLC

 

("Brand Architekts" or the "Company" or the "Group")

 

Trading Update & Resolution of Legal Claim

 

 

Brand Architekts Group plc, a challenger British Beauty brand business, announces an update on trading for the 52 weeks to 30 June 2023 and a resolution of its legal claim with its joint venture counterpart in Mr Haircare Ltd.

Group sales for FY23 are expected to be c.£20.1million (FY22: £14.2m) an increase of 41% on the prior year due primarily to the full year effect of the acquisition of InnovaDerma Plc, which completed end of May 2022. Excluding InnovaDerma, revenue increased by c7% due to strong international sales offset by challenging trading conditions in UK channels.

 

Despite the challenging trading environment the Group generated a reduced operating loss in H2, a significant improvement on the performance in H1, due to a focus on better targeted advertising & promotions resulting in improved contribution. Full year losses are expected to see similar improvement.

 

The Group retains a healthy net cash position of c£8.2m at the year-end, slightly better than the position at the half year and also slightly ahead of market expectations.

 

Business Highlights

· Continued implementation of the strategy to invest and support our Invest & Nurture brands, which command higher retail prices, engender strong consumer loyalty and deliver stronger margins.

· Completed integration of InnovaDerma, core functions now based in the UK, full synergies to be realised by January 2024.

· New Super Facialist Clear Skin, targeting problematic teenage skin care needs, launched on Amazon in September and in Boots in June 23.

· New Super Facialist D2C site launched in March 23

· New Skinny Tan brand awareness and customer acquisition campaigns launched in July 2023 to capitalise on the tanning season.

· The Solution Menopause range to launch in 2024.

· Strong growth vs the prior year in international channel sales driven by post COVID-19 rebound in volumes from General Merchandise stores across North America and Europe, benefitting Dirty Works.

· Confirmed distribution roll out to AS Watson stores in 2023 & 2024 across the Middle East and Asia (Thailand - 200 stores, Vietnam - 7, The Gulf - 16, Philippines - 100, Malaysia - 66, Taiwan - 200, Singapore - 40, Turkey -100).

 

 

Mr Haircare Limited:

As announced at the time of the Groups' final results in November, the Group was subject to a legal claim brought by Jamie Stevens Media Limited (JSML), its joint venture counterparty/co-shareholder in Mr Haircare Ltd (premium male haircare brand), which alleged a breach of shareholders' agreement between the parties dating back to the company's acquisition of Fish in 2018. After taking appropriate legal advice and following constructive dialogue the Group has agreed to a full and final settlement of all claims in the sum of £200,000 together with legal costs of £225,000.

 

The Company has also agreed to purchase JSML's 55% shareholding in Mr Haircare Ltd in cash at a fair value price to be determined by an external valuer later in the year. MR sales for FY23 are expected to be £0.54m (FY22 £0.5m). The transaction is expected to conclude before the end of the 2023 calendar year and a further announcement will be made in due course. The proposed acquisition of the remaining JV shares is in line with the company's strategic vision to invest and build its portfolio of high-performance, problem-solving and margin accretive brands. The brand will be relaunched as 'MR' and the company's vision is to expand the brand into adjacent male grooming problem solving categories and invest in the master brand to accelerate brand awareness and stimulate consumer trial.

Outlook:

Against a backdrop of continued challenging market conditions and inflationary pressures the management team is focused on realising both the strategic and financial aims of the Group. The immediate priorities are driving brand awareness of key invest and nurture brands, delivering revenue synergies through international expansion, a laser focus on brand contribution and releasing working capital tied up in harvest brands. We remain confident that the foundations we are building will enable us to return to profitability and achieve our medium and long-term goals. 

 

The Group expects to announce its full year results for the 52 weeks to 30 June 2023 in late October.

Quentin Higham, Chief Executive, commented:

"We have successfully integrated InnovaDerma and the new team has worked extremely hard in focussing on improving brand contribution. We continue to focus our resources on our key invest and nurture brands. I am positive about the future and optimistic to see the growth potential in our performance focussed portfolio. We are confident that our brand development and brand reach strategic pillars will help us achieve our profit goals."

 

 

For further information please contact:

Brand Architekts Group PLC

Quentin Higham / Geoff Ellis

 

 

 

 

Singer Capital Markets

Shaun Dobson / Jen Boorer / Alex Emslie

(Nominated adviser and broker)

020 7496 3000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKCBNKBKBCOD
Date   Source Headline
17th Apr 20242:00 pmRNSHolding(s) in Company
2nd Apr 20245:35 pmRNSHolding(s) in Company
2nd Apr 20244:35 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSInterim results
15th Dec 202311:34 amRNSGrant of share options
14th Dec 202310:16 amRNSGrant and cancellation of share options
12th Dec 20234:02 pmRNSResult of AGM
1st Dec 20237:00 amRNSJoint Venture Settlement: Mr Haircare Limited
31st Oct 20237:00 amRNSFinal Results
19th Sep 20234:48 pmRNSBoard Responsibilities Update
20th Jul 20237:00 amRNSTrading Update & Resolution of Legal Claim
12th Jun 202310:30 amRNSGrant of Options
6th Jun 20237:00 amRNSBoard Responsibilities
31st May 20237:00 amRNSRule 19.6(c) confirmation
26th May 20237:00 amRNSDirectorate Changes
21st Mar 20237:00 amRNSInterim Results
24th Jan 20237:00 amRNSDirectorate Change & Trading Update
19th Dec 20224:24 pmRNSResult of AGM
28th Nov 20227:00 amRNSDirectorate Change
24th Nov 202211:50 amRNSAnnual Report and Accounts & Notice of AGM
16th Nov 202211:19 amRNSHolding(s) in Company
9th Nov 20225:00 pmRNSHolding(s) in Company
8th Nov 20225:16 pmRNSHolding(s) in Company
8th Nov 20227:00 amRNSFinal Results
27th Oct 20227:00 amRNSNotice of Results and Investor Presentation
25th Oct 202210:16 amRNSHolding(s) in Company
3rd Aug 20223:30 pmRNSHolding(s) in Company
3rd Aug 20229:21 amRNSHolding(s) in Company
3rd Aug 20229:19 amRNSHolding(s) in Company
21st Jul 20227:00 amRNSTrading Update
14th Jul 20227:00 amRNSHolding(s) in Company
4th Jul 202211:02 amRNSHolding(s) in Company
1st Jul 202211:44 amRNSHolding(s) in Company
30th Jun 20223:53 pmRNSHolding(s) in Company
30th Jun 20221:41 pmRNSHolding(s) in Company
16th Jun 20229:03 amRNSBoard Appointment
10th Jun 202212:35 pmRNSHolding(s) in Company
10th Jun 202212:10 pmRNSDirector/PDMR Shareholding
7th Jun 20224:34 pmRNSHolding(s) in Company
7th Jun 20224:28 pmRNSHolding(s) in Company
7th Jun 202211:51 amRNSHolding(s) in Company
7th Jun 202211:48 amRNSHolding(s) in Company
7th Jun 202211:47 amRNSHolding(s) in Company
31st May 20221:57 pmRNSScheme of Arrangement Becomes Effective
31st May 20229:52 amRNSForm 8.5 (EPT/RI)
30th May 202211:54 amRNSForm 8.5 (EPT/RI)
27th May 20224:01 pmRNSCourt Sanction of Scheme and Suspension
20th May 202211:34 amRNSForm 8.5 (EPT/RI)
19th May 20224:56 pmRNSResult of General Meeting
17th May 202212:03 pmRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.